Abstract:Background: It is one of key subjects to evaluate the the effect of endothelial nitric oxide synthase (eNOS) activity on endothelial cell culture, which has important significance for preparing tissue engineered vascular grafts. Objective: To construct the eukaryotic expression vector pcDNA3.1/eNOS for detecting the transfection efficiency of eNOS in vascular endothelial cells and to evaluate the effect of eNOS activity on endothelial cell culture. Design, Time and Setting: The single sample observation was performed at the Labboratory of Biochemistry, Affiliated Drum Tower Hospital of Nanjing University Medical School from July 2005 to May 2007. Materials: Plasmid PCMV-eNOS was presented by Zhang Qun-lin, a professor from Yunyang Medical College. Eukaryotic expression vector pcDNA3.1 was presented by Jia Li-jun, a post-doctor from Nanjing University. The pcDNA3.0/EGFP was provided by Doctor Qi Jin-liang and DH5a and ECV304 were conserved by the Biology Department of Nanjing University. Methods: The full-length human eNOS cDNA(3.6kb) was isolated from pCMV/ eNOS by restriction enzyme digest with Ecorl, and then ligated into the EcorI cloning site of the pcDNA3.1 expression plasmid and judged the eNOS direction by restriction enzynme digest with Xho I to construct recombint pcDNA3.1/eNOS. Co-transfection of pcDNA3.1/eNOS with pcDNA3.0/ EGFP mediated by Lipofectamine into human umbilical vein endothelial cells (ECV304) was performed. Main Outcome Measures: Transfection rate and effect of ECV304 proliferation were calculated by fluorescence microscope and flow cytometer. RT-PCR and immunocytochemistry were used to detect the status of eNOS expression. When treated ECV304 with four independent factors including Ca2+, L-arginine(L-Arg), Ethylene Diamine Tetraacetic Acid (EDTA) and N-nitro-L-arginine methylester (L-NAME), the eNOS activity and nitric oxide release were detected. Meanwhile, changes in the ECV304 proliferation were examined. Results: After transfected liposome into human ECV304, the pcDNA3.1/eNOS transfection rate was 35.6%±3.4%, eNOS mRNA and protein expression of eNOS in the transfected ECV304 group had significant difference compared with the control group. Meanwhile, the basal activity of eNOS had obvious differences in each group. On the whole, the ECV304 growth curve was downward as increasing nitric oxide concentration. Conclusion: Eukaryotic expression vector pcDNA3.1/eNOS was successfully constructed and can effectively transfect into ECV304. However, the eNOS was not active until treated with Ca2+ in vitro. Proliferation of ECV304 was inhibited by high-concentration of nitric oxide.

Endothelial nitric oxide synthase expression in endothelial cells following aukaryotic expression vector construction